Literature DB >> 2299073

The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies.

L D Yang1, D S Berman, H Kiat, K J Resser, J D Friedman, A Rozanski, J Maddahi.   

Abstract

The frequency of thallium-201 late reversibility was prospectively assessed in 118 patients who had stress-redistribution thallium-201 studies by single photon emission computed tomography (SPECT). These patients demonstrated two or more segments with nonreversible defects at 4 h imaging and underwent late (18 to 72 h) redistribution imaging. When the criterion of late reversibility was defined as greater than or equal to 1 segment with 4 h nonreversible defects demonstrating late reversibility, it was present in 62 (53%) of the 118 patients and 164 (22%) of 762 segments. When the criterion of greater than or equal to 2 segments was used, late reversibility was found in 41 (35%) of 118 patients and 143 (19%) of 762 segments. The frequency of detected reversible defects increased from 27% at 4 h imaging to 43% at combined 4 h and late imaging (p less than 0.0001) and was significantly increased in all myocardial regions. In comparing the efficacy of initial and late imaging alone versus performing initial, 4 h and late imaging for the identification of reversible defects, 421 (94%) of 449 segments classified as reversible by the latter protocol were also correctly identified by the early and late imaging only approach, with the remaining 6% (28 segments) comprising those segments demonstrating the reversible pattern at 4 h and the nonreversible pattern at late imaging. No major differences were noted with respect to clinical, stress electrocardiographic and scintigraphic variables between the 118 patients undergoing late imaging and 98 additional randomly selected patients with two or more nonreversible defects at 4 h, who did not have late imaging.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2299073     DOI: 10.1016/s0735-1097(10)80057-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

1.  A survey of nuclear cardiological practice in Great Britain. The British Nuclear Cardiology Group.

Authors:  R Underwood; C Gibson; A Tweddel; J Flint
Journal:  Br Heart J       Date:  1992-03

2.  A challenge to the nuclear cardiology laboratory: imaging goals in patients after infarction.

Authors:  T P Rocco; M A Pfeffer
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

3.  Comparative accuracy of various Tl-201 reinjection imaging protocols to detect myocardial viability.

Authors:  H Naruse; T Kondo; T Arii; M Morita; M Ohyanagi; T Iwasaki; M Fukuchi
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 4.  Radionuclide techniques for the assessment of myocardial viability.

Authors:  E Skoufis; A I McGhie
Journal:  Tex Heart Inst J       Date:  1998

5.  Nuclear cardiology: the interventionalists' perspective.

Authors:  H L Haronian; H S Cabin
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

6.  Thallium 201 for detection of viable myocardium: comparison of different reinjection protocols.

Authors:  L Favaro; F Masini; W Serra; G Gavaruzzi; G Benecchi; S Tagliavini; G Botti
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

Review 7.  Non-invasive assessment of residual viability in post-myocardial infarction patients. Role of nuclear techniques.

Authors:  O Parodi; P Marzullo; G Sambuceti; D Neglia; A Gimelli; A Giorgetti
Journal:  Int J Card Imaging       Date:  1993

8.  Value of thallium-201 early reinjection for assessment of myocardial viability.

Authors:  H Yoshida; K Sakata; M Mochizuki; T Kouyama; Y Matsumoto; M Takezawa; M Yoshimura; N Ono; N Mori; S Yokoyama
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

9.  Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.

Authors:  C Altehoefer; J vom Dahl; U Buell; R Uebis; E Kleinhans; P Hanrath
Journal:  Eur J Nucl Med       Date:  1994-01

10.  Noninvasive assessment of coronary microvascular dysfunction using Tc-99m tetrofosmin SPECT in patients with acute myocardial infarction.

Authors:  Yoshiteru Abe; Makoto Kondo; Tomoyuki Kubota; Ryota Matsuoka; Makoto Araki; Kiyoshi Doyama; Hitoshi Tanio
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.